Canopy Growth Corporation (CGC)
CGCNASDAQ-GS Medicinal Chemicals and Botanical Products
$0.5905
-0.0323 (-5.19%) today
Regular session, Nov 10, 1:52 PM ET
- Market cap
- $249.99m
- P/E
- –
- EPS, last 4 quarters
- $-0.3600
- Dividend yield
- –
- Day range
- $0.5800 to $0.6200
- 52-week range
- $0.5809 to $2.38
- Average volume
- 2.40m
- Previous close
- $0.6228
Analysts
2 coveringHold0 buy, 2 hold, 0 sell
Targets a year out average $0.9000, +52.4% from here
Earnings
next estimate $-0.0200Next report
Dec 2025
-233.3%
Mar 2026
-183.3%
Jun 2026
+50.0%
Sep 2026
-250.0%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $67.80m | $57.29m | $100.36m | $40.41m |
| Gross profit | $16.09m | $5.12m | $22.24m | $9.88m |
| Operating income | -$19.65m | -$67.79m | -$22.11m | -$9.64m |
| Net income | -$41.36m | -$111.21m | -$14.58m | -$24.35m |
Last four quarters: revenue $265.87m, margin -72.0%, free cash flow -$56.46m
News
8 latest- Which of These 5 Cannabis Stocks Has the Strongest Balance Sheet?The Motley Fool · 2 days ago
- Canopy Growth Corporation: 3 Key Takeaways for Long-Term InvestorsThe Motley Fool · 3 days ago
- Canopy Growth (CGC) Q2 2027 Earnings Call TranscriptThe Motley Fool · 4 days ago
- Canopy Growth Q2 Earnings Call HighlightsMarketBeat · 4 days ago
- Canopy Growth Corporation Q2 Loss Increases RTTNews · 4 days ago
- Canopy Growth Corporation (CGC) Reports Q2 Loss, Lags Revenue EstimatesZacks · 4 days ago
- Concentra Group (CON) Tops Q3 Earnings and Revenue EstimatesZacks · 5 days ago
- Canopy Growth vs. Tilray Brands: Quarterly Revenue Scale and Consistency in CannabisThe Motley Fool · Oct 30, 2026
The company
Canopy Growth is a leading global company committed to bettering lives through cannabis. With a focus on cultivation excellence, quality, trust, innovation and disciplined execution, Canopy Growth is a consumer-centric company serving patients, consumers and partners alike. The Company's portfolio of owned and licensed brands, including Tweed, 7ACRES, DOJA, Deep Space, DeeLish, Claybourne, MTL Cannabis, Low Key by MTL and R'belle, as well as category-defining Storz & Bickel, delivers innovative cannabis products to consumers across Canada and beyond. It is also Canada's leading provider of medical cannabis services through Spectrum Therapeutics, Abba Medix, Apollo, and Canada House Clinics. The Company also holds an unconsolidated, non-controlling interest in Canopy USA, LLC, which provides exposure to the U.S. THC market.
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ-GS
- Region
- North America
- Website
- canopygrowth.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.